SOD1 and juvenile Huntington disease: The RfxCas13d system has also been used in silencing targeted mRNA to improve outcomes in the nervous system [36] (SOD1 and HTT in a model of amyotrophic lateral sclerosis and Huntington’s disease, respectively).